Anew Medical, Inc.
Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic par… Read more
Anew Medical, Inc. (WENA) - Total Liabilities
Latest total liabilities as of June 2024: $4.86 Million USD
Based on the latest financial reports, Anew Medical, Inc. (WENA) has total liabilities worth $4.86 Million USD as of June 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Anew Medical, Inc. - Total Liabilities Trend (2021–2023)
This chart illustrates how Anew Medical, Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Anew Medical, Inc. Competitors by Total Liabilities
The table below lists competitors of Anew Medical, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ikapharmindo Putramas Tbk.
JK:IKPM
|
Indonesia | Rp239.93 Billion |
|
Dave Inc. Warrants
NASDAQ:DAVEW
|
USA | $141.94 Million |
|
Quantum Genomics SA
PA:ALQGC
|
France | €2.81 Million |
|
Prg Holdings Bhd
KLSE:7168
|
Malaysia | RM264.38 Million |
|
Tincorp Metals Inc.
OTCQX:TINFF
|
USA | $2.33 Million |
|
Norwest Minerals Ltd
AU:NWM
|
Australia | AU$940.49K |
Liability Composition Analysis (2021–2023)
This chart breaks down Anew Medical, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -3.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anew Medical, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anew Medical, Inc. (2021–2023)
The table below shows the annual total liabilities of Anew Medical, Inc. from 2021 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $8.24 Million | +67.19% |
| 2022-12-31 | $4.93 Million | +32470.18% |
| 2021-12-31 | $15.13K | -- |